No Improvement in Treatment Success with Teriparatide Use for Hip and Pelvic Bone Fractures
How to Cite
OrthoEvidence. No Improvement in Treatment Success with Teriparatide Use for Hip and Pelvic Bone Fractures. ACE Report. 2021;10(1):10. Available from: https://myorthoevidene.com/AceReport/Report/12872
Effects of Teriparatide on Treatment Outcomes in Osteoporotic Hip and Pelvic Bone Fractures: Meta-analysis and Systematic Review of Randomized Controlled Trials.Hip Pelvis. 2020 Dec; 32(4): 182–191.
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
A total of 5 randomized controlled trials containing a total of 386 patients were included in this meta-analysis comparing teriparatide (n=181) and placebo (n=205) for the treatment of osteoporotic hip and pelvic bone fractures. The primary outcome of interest was the pooled incidence of treatment failure. Mean follow up of the included studies ranged from 3 to 19.5 months. Results of the meta-ana...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE